Tesofensine is primarily investigated for its potential in weight management and treatment of obesity. It functions by inhibiting the reuptake of neurotransmitters such as dopamine, norepinephrine, and serotonin, which can lead to reduced appetite and increased energy expenditure. Clinical studies have shown promising results in significant weight loss among participants, making it a candidate for addressing obesity-related health issues. Additionally, it is being explored for its potential in treating neurodegenerative disorders like Parkinson’s disease, as its mechanism of action may help regulate dopamine levels, which are crucial in managing motor functions. However, further research is needed to fully understand its efficacy and safety profile in these applications.